What are the warning signs of severe dengue?

Warning signs appear during the critical phase (day 3–7), often as the fever breaks: severe abdominal pain, persistent vomiting, rapid breathing, bleeding gums or nose, fatigue with restlessness, liver enlargement, vomiting blood. These require immediate hospital care as the patient may progress to dengue shock syndrome.

Why is ibuprofen dangerous in dengue?

Dengue causes low platelet counts (thrombocytopenia). Ibuprofen and other NSAIDs inhibit platelet function and can cause gastric bleeding — dramatically increasing hemorrhage risk. Only paracetamol (acetaminophen) is safe for fever management in dengue.

Can you get dengue twice?

Yes, and the second infection is often more severe. There are four dengue serotypes (DENV 1–4). Infection with one provides lifelong immunity to that serotype but temporary immunity to the others. A second infection with a different serotype triggers Antibody-Dependent Enhancement (ADE), which can make the disease much more severe.

Is there a dengue vaccine?

Dengvaxia (CYD-TDV by Sanofi) is approved in several countries for people aged 9–45 who have previously had dengue confirmed by a test. It is NOT recommended for dengue-naive individuals (those who have never had dengue) because it can increase risk of severe dengue in that group. A new vaccine, TAK-003 (Qdenga by Takeda), approved in Europe, Indonesia, and Brazil from 2022, does not have this restriction and works in seropositive and seronegative individuals.

DengueMosquito-borneTropical Disease

What Is Dengue Fever? Symptoms, Warning Signs & Treatment

Published: January 2025 · Updated: June 2025 · Not medically reviewed

The world's fastest-spreading mosquito-borne viral disease — and why knowing the warning signs could save a life.

VirusWatch Editorial Team — Researched and written by the VirusWatch editorial team using WHO and CDC public data · Last reviewed: May 2025

Medical Disclaimer: Educational content only. If you have fever and suspect dengue, seek medical care immediately — do NOT take ibuprofen or aspirin.

Dengue by the Numbers

Dengue is the most rapidly spreading mosquito-borne viral disease in the world. An estimated 390 million dengue infections occur globally each year — though only 96 million cause clinical illness. Roughly 40% of the world's population (3.9 billion people) live in areas at risk. In 2024, dengue cases reached record levels globally, with outbreaks in Europe (Italy, France), South America, and the Caribbean at unprecedented scale.

The Virus: Four Serotypes

Dengue fever is caused by dengue virus (DENV), a flavivirus in the Flaviviridae family — the same family as Zika, Yellow Fever, and West Nile virus. There are four distinct serotypes: DENV 1, 2, 3, and 4. Each is antigenically distinct enough that immunity to one does not protect against the others.

This four-serotype structure creates a critical immunological problem: a second infection with a different serotype can be far more severe than the first, due to Antibody-Dependent Enhancement (ADE). Pre-existing cross-reactive antibodies from the first infection do not neutralize the new serotype effectively but instead help it enter monocytes and macrophages more efficiently, dramatically amplifying viral replication and triggering a more intense immune response.

The Mosquito Vector

Aedes aegypti is the primary vector — a mosquito species uniquely adapted to human environments, breeding in small quantities of standing water (flower pots, tyres, water storage containers, blocked gutters). Unlike malaria-transmitting mosquitoes which bite at dawn and dusk, Aedes aegypti bites during daylight hours, making bednets less effective for dengue prevention. It is found throughout tropical and subtropical regions.

Aedes albopictus (the Asian tiger mosquito) is a secondary vector with a wider geographic range that extends into temperate climates — responsible for dengue transmission in parts of Europe and the eastern US.

The Clinical Timeline

Febrile Phase (Day 1–3)

Sudden-onset high fever (39–40°C), severe headache, retro-orbital pain (pain behind the eyes — characteristic of dengue), myalgia and arthralgia ("breakbone fever" — so severe it was nicknamed for the sensation of bones breaking), flushed face. Initial rash may appear. Mild bleeding phenomena (petechiae, easy bruising) may be noted.

Critical Phase (Day 3–7) — DANGER ZONE

This is the most dangerous phase, and paradoxically often begins as the fever breaks — patients (and families) mistakenly think they're improving. Plasma leakage occurs as vascular permeability increases. Platelet counts fall (thrombocytopenia). Warning signs indicating hospital admission is urgent:

Severe abdominal pain or abdominal tenderness
Persistent vomiting (3+ episodes in 24 hours)
Clinical fluid accumulation (ascites, pleural effusion)
Mucosal bleeding (nose, gums, vaginal)
Lethargy or restlessness
Liver enlargement (>2 cm)
Rising hematocrit with rapid platelet decline

If plasma leakage is severe, Dengue Shock Syndrome (DSS) develops — circulatory failure requiring emergency IV fluid resuscitation.

Recovery Phase (Day 7–10)

Reabsorption of leaked fluids. Risk of fluid overload (including pulmonary edema) if IV fluids are not carefully titrated in this phase. Bradycardia common. Classic convalescent rash: white islands in a sea of red. Platelet count normalizes. Fatigue can persist for weeks.

The Critical Rule: No Ibuprofen, No Aspirin

NEVER take ibuprofen, aspirin, naproxen, or other NSAIDs for dengue fever. These drugs inhibit platelet function and can cause severe GI bleeding — potentially fatal in a disease that already depletes platelets. ONLY paracetamol (acetaminophen) is safe for fever and pain in dengue.

Diagnosis

NS1 antigen test: Detects dengue antigen in the blood; positive from Day 1 to approximately Day 5. Best early-phase test.
Dengue IgM/IgG serology: IgM appears from Day 4–5; IgG from Day 7+. IgM positive + IgG negative = primary dengue. Both positive = secondary dengue (ADE risk).
RT-PCR: Highly sensitive, detects viral RNA from Day 1–5. Gold standard for confirmation. Not always available in endemic areas.
Complete blood count (CBC): Monitor platelet count and hematocrit daily during critical phase.

Treatment

There is no specific antiviral treatment for dengue. Management is supportive:

Hydration: Oral rehydration salts for mild cases; IV fluids carefully titrated in severe disease
Fever management: Paracetamol only
Platelet monitoring: Daily CBC during critical phase
Platelet transfusion: Only for active significant bleeding — not routinely for low counts alone
Hospitalization criteria: Warning signs, platelet count below 100,000/μL, or inability to maintain oral hydration

Prevention and the Wolbachia Revolution

Personal protection: DEET repellents, permethrin-treated clothing, wearing long sleeves/pants, avoiding outdoor activity at peak mosquito-feeding times (early morning and late afternoon).

Environmental control: Eliminating standing water — the single most effective community intervention. Aedes aegypti breeds in as little as a bottle cap of water.

Wolbachia technology: A breakthrough biological approach. Aedes aegypti mosquitoes infected with Wolbachia bacteria have a dramatically reduced ability to carry and transmit dengue virus. When released, Wolbachia-carrying mosquitoes outcompete wild-type mosquitoes and the Wolbachia spreads through the population. Field trials in cities in Australia, Indonesia, Colombia, and Brazil showed 77% reduction in dengue cases. The WHO has endorsed this approach; large-scale deployment is underway.

Vaccines: TAK-003 (Qdenga, Takeda) — approved in Europe, Indonesia, Brazil, and several other countries from 2022–2023. Two doses; effective in both dengue-seropositive and seronegative individuals (unlike Dengvaxia). Particularly effective against DENV 1 and 2; moderate protection against DENV 3 and 4.

Get Outbreak Alerts

regularly updated dengue and infectious disease outbreak notifications, free to your inbox.

Frequently Asked Questions

Warning signs appear during the critical phase (typically day 3–7) and require immediate hospital assessment: severe abdominal pain, persistent vomiting, bleeding from gums or nose, blood in vomit or stool, rapid breathing, sudden improvement in fever followed by deterioration (the "dengue gap"), extreme fatigue, or restlessness. Never assume improving fever means recovery — this is when many dengue deaths occur.

Yes. There are four dengue serotypes (DENV 1–4). Infection with one provides lifelong immunity to that serotype but only temporary cross-immunity to others. A second infection with a different serotype can be more severe due to Antibody-Dependent Enhancement (ADE) — pre-existing antibodies help the new serotype infect cells more efficiently.

Most dengue infections are self-limiting with proper supportive care. The overall case fatality rate is less than 1% in countries with good healthcare. However, untreated severe dengue (dengue hemorrhagic fever, dengue shock syndrome) can be fatal. Key to survival: early recognition of warning signs and timely medical care with proper fluid management.

Both cause fever, headache, and muscle pain. Dengue-specific features include: retro-orbital pain (pain behind the eyes when moving them), the rash pattern (appearing day 3–5), petechiae (tiny red dots from capillary bleeding), and the dengue timeline with a critical phase as fever breaks. If you're in a dengue-endemic area with these symptoms, seek medical testing — an NS1 antigen test can confirm dengue from day 1.

Sources: WHO dengue guidelines 2009 (revised 2012); Lancet Infectious Diseases; NEJM; Bhatt et al. Nature 2013 (390 million dengue infections estimate); Wolbachia WMP trial data.